EVENTS & PRESENTATIONS

Events

GenomeFrontier Awarded $100,000 G-Rex® Grant to Advance Non-Viral CAR T Cell Therapy, GF-CART01
Read more
Our Founder/CEO/CSO, Sareina Wu and Director of Clinical development, Howard Cheng will present our work as invited expert speakers at the 10th Annual CAR-TCR Summit in Boston, US. (September 23-26, 2025)
Read more
Our Founder/CEO/CSO, Sareina Wu will present our work as invited expert speakers and our COO/CSO, Karen Wen will present as invited moderator at the 2025 Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conferencein Taipei, Taiwan. (May 26-27, 2025)
Read more
Taiwan FDA clears GenomeFrontier’s IND application for GF-CART01, a CD20/CD19 dual targeting CAR T cell therapy for hematological B cell malignancies!
Read more
Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific communication, Marcus J. Calkins, will present our work as invited expert speakers at the 9th Annual CAR-TCR Summit in Boston, US. (September 17-20, 2024)
Read more